HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Layde, P M Articles by Oakley, G P Search for Related Content PubMed PubMed Citation Articles by Layde, P M Articles by Oakley, G P, Jr

Maternal serum alpha-fetoprotein screening: a cost-benefit analysis.

P M Layde, S D von Allmen and G P Oakley, Jr

The prenatal detection of fetal neural tube defects (NTD) is now possible by means of a multi-tiered program utilizing maternal serum alpha-fetoprotein (MSAFP) screening coupled with ultrasonography and amniocentesis where indicated. This paper considers the economic consequences of screening for fetal NTD a theoretical cohort of 100,000 pregnant women at risk of having an affected fetus who would elect to terminate their pregnancies if an affected fetus were found. The cost of the program was balanced against the benefits of the program, such as the averted costs of institutionalization, medical care, and the like. The total cost of the program to screen 100,000 such women was calculated to be $2,047,780, or slightly over $20 per woman screened, while the total economic benefits exceeded $4,000,000.

This article has been cited by other articles:

				T. G. Ganiats Justifying Prenatal Screening and Genetic Amniocentesis Programs by Cost-Effectiveness Analyses: A Re-evaluation Med Decis Making, February 1, 1996; 16(1): 45 - 50. [Abstract] [PDF]

				P.A. Baird and A.D. Sadovnick Survival in Infants with Anencephaly Clinical Pediatrics, May 1, 1984; 23(5): 268 - 271. [Abstract] [PDF]